A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.
Medicines Discovery Catapult launches a Virtual R&D Discovery Services platform made up of more than 20 CROs, which will help support small- to medium-sized companies deliver drug discovery projects.